Tarsus Pharmaceuticals Ownership | Who Owns Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals Ownership Summary
Tarsus Pharmaceuticals is owned by 105.80% institutional investors, 3.16% insiders. Blackrock is the largest institutional shareholder, holding 9.25% of TARS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.82% of its assets in Tarsus Pharmaceuticals shares.
TARS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Tarsus Pharmaceuticals | 105.80% | 3.16% | -8.96% |
| Sector | Healthcare Stocks | 42.50% | 10.81% | 46.69% |
| Industry | Biotech Stocks | 45.24% | 10.75% | 44.01% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 3.27M | 9.25% | $88.79M |
| Blackrock funding, inc. /de | 3.78M | 8.92% | $224.62M |
| Rtw investments, lp | 3.18M | 7.50% | $188.84M |
| Deep track capital, lp | 3.00M | 7.08% | $178.29M |
| Paradigm biocapital advisors lp | 2.67M | 6.29% | $158.42M |
| Cowen and company | 2.20M | 6.22% | $59.72M |
| Jennison associates | 2.60M | 6.15% | $154.79M |
| Tang capital management | 2.45M | 5.79% | $145.89M |
| Vanguard group | 2.27M | 5.36% | $135.03M |
| Morgan stanley | 1.91M | 4.51% | $113.65M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tang capital management | 2.45M | 5.62% | $145.89M |
| Deep track capital, lp | 3.00M | 4.98% | $178.29M |
| Capricorn fund managers | 240.02K | 4.79% | $14.26M |
| Paradigm biocapital advisors lp | 2.67M | 4.51% | $158.42M |
| Bioimpact capital | 341.50K | 3.32% | $20.30M |
| Ally bridge group (ny) | 70.78K | 2.56% | $4.21M |
| Cutter capital management, lp | 112.50K | 2.55% | $6.23M |
| Rtw investments, lp | 3.18M | 2.33% | $188.84M |
| Sands capital ventures | 170.00K | 2.21% | $10.10M |
| Frazier life sciences management | 1.17M | 2.08% | $69.39M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deep track capital, lp | 3.00M | 4.98% | 1.25M |
| Blackrock | 3.27M | 0.00% | 614.03K |
| Millennium management | 644.01K | 0.02% | 421.50K |
| Loomis sayles & co l p | 389.90K | 0.03% | 389.90K |
| Timessquare capital management | 267.50K | 0.23% | 267.50K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Exoduspoint capital management, lp | - | - | -883.04K |
| Vivo capital | - | - | -565.55K |
| Adage capital partners gp | - | - | -543.00K |
| Toronto dominion bank | 617.58K | 0.06% | -384.38K |
| J. goldman & co lp | 44.30K | 0.07% | -320.26K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Loomis sayles & co l p | 389.90K | 0.03% | 389.90K | $23.17M |
| Timessquare capital management | 267.50K | 0.23% | 267.50K | $15.90M |
| Capricorn fund managers | 240.02K | 4.79% | 240.02K | $14.26M |
| Caption management | 160.00K | 0.07% | 160.00K | $4.35M |
| Affinity asset advisors | 125.00K | 0.65% | 125.00K | $7.43M |
Sold Out
| Holder | Change |
|---|---|
| Twin peaks wealth advisors | -1.00 |
| Nelson, van denburg & campbell wealth management group | -5.00 |
| Capital performance advisors llp | -5.00 |
| Riggs asset managment | -10.00 |
| Stephens consulting | -10.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 217 | 10.15% | 44,818,385 | 5.19% | 105 | 1.05% | 105 | -17.32% | 85 | 80.85% |
| Jun 30, 2025 | 202 | 6.32% | 46,119,790 | 6.86% | 108 | 0.90% | 127 | 30.93% | 49 | -30.99% |
| Mar 31, 2025 | 193 | -3.02% | 43,559,205 | 8.22% | 110 | 1.01% | 100 | -16.67% | 71 | 29.09% |
| Dec 31, 2024 | 62 | -63.10% | 11,285,757 | -73.99% | 29 | 0.23% | 40 | -58.33% | 14 | -68.18% |
| Sep 30, 2024 | 168 | 9.80% | 43,393,921 | 8.30% | 113 | 0.88% | 96 | 2.13% | 44 | 2.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.19M | 2.82% | -24.83K |
| Vanguard US Total Market Shares ETF | 1.14M | 2.73% | - |
| iShares Russell 2000 ETF | 932.92K | 2.21% | - |
| Jennison SMid Cap Core Equity | 682.75K | 1.63% | 17.89K |
| PGIM Jennison Small Company A | 682.75K | 1.62% | 1.95K |
| AZ InvestEd Ivy Small Cap Growth E | 551.28K | 1.31% | 22.32K |
| MEDICAL BioHealth EUR Acc | 527.77K | 1.25% | - |
| Macquarie Small Cap Growth C | 478.19K | 1.13% | -73.10K |
| Invesco Small Cap Value A | 457.84K | 1.09% | -51.75K |
| Vanguard Institutional Extnd Mkt Idx Tr | 413.47K | 0.98% | -181.14K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 24, 2025 | Azamian Bobak R. | President/CEO and Board Chair | Sell | $332.22K |
| Sep 08, 2025 | LINK WILLIAM J PHD | - | Sell | $1.55M |
| Aug 11, 2025 | Azamian Bobak R. | President/CEO and Board Chair | Sell | $300.00K |
| Jun 17, 2025 | Farrow Jeffrey S | See Remarks | Sell | $550.04K |
| Jun 16, 2025 | Lin Elizabeth Yeu | Chief Medical Officer | Sell | $41.33K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 3 |
| 2025 Q2 | - | 3 |
| 2025 Q1 | - | 19 |
| 2024 Q4 | - | - |
| 2024 Q3 | - | 2 |
TARS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools